{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T08:06:08Z","timestamp":1789977968954,"version":"4.0.1"},"reference-count":49,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","medical.theclinics.com","clinicalkey.es","theclinics.com","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medical Clinics of North America"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1016\/j.mcna.2016.09.011","type":"journal-article","created":{"date-parts":[[2016,12,10]],"date-time":"2016-12-10T10:16:23Z","timestamp":1481364983000},"page":"417-429","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Unusual Anemias"],"prefix":"10.1016","volume":"101","author":[{"given":"Molly Maddock","family":"Daughety","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas G.","family":"DeLoughery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.mcna.2016.09.011_bib1","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1016\/j.pcl.2013.08.008","article-title":"Thalassemias","volume":"60","author":"Martin","year":"2013","journal-title":"Pediatr Clin North Am"},{"issue":"20","key":"10.1016\/j.mcna.2016.09.011_bib2","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1056\/NEJMra1404415","article-title":"The alpha-thalassemias","volume":"371","author":"Piel","year":"2014","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.mcna.2016.09.011_bib3","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.1365-2141.2009.08054.x","article-title":"Significant haemoglobinopathies: guidelines for screening and diagnosis","volume":"149","author":"Ryan","year":"2010","journal-title":"Br J Haematol"},{"issue":"3","key":"10.1016\/j.mcna.2016.09.011_bib4","doi-asserted-by":"crossref","first-page":"472","DOI":"10.3324\/haematol.2011.052357","article-title":"Iron deficiency does not compromise the diagnosis of high HbA(2) beta thalassemia trait","volume":"97","author":"Passarello","year":"2012","journal-title":"Haematologica"},{"issue":"1","key":"10.1016\/j.mcna.2016.09.011_bib5","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1097\/MOH.0b013e32834da9d2","article-title":"Update on anemia and neutropenia in copper deficiency","volume":"19","author":"Lazarchick","year":"2012","journal-title":"Curr Opin Hematol"},{"issue":"6","key":"10.1016\/j.mcna.2016.09.011_bib6","first-page":"869","article-title":"Copper deficiency myelopathy","volume":"257","author":"Jaiser","year":"2010","journal-title":"J\u00a0Neurol"},{"issue":"12","key":"10.1016\/j.mcna.2016.09.011_bib7","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1152\/japplphysiol.00248.2015","article-title":"Adaptation of iron requirement to hypoxic conditions at high altitude","volume":"119","author":"Gassmann","year":"2015","journal-title":"J\u00a0Appl Physiol (1985)"},{"key":"10.1016\/j.mcna.2016.09.011_bib8","doi-asserted-by":"crossref","DOI":"10.1111\/ejh.12776","article-title":"Epidemiology of iron deficiency anaemia in four European countries: a population-based study in primary care","author":"Levi","year":"2016","journal-title":"Eur J Haematol"},{"issue":"9","key":"10.1016\/j.mcna.2016.09.011_bib9","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1136\/jclinpath-2014-202837","article-title":"The risk of copper deficiency in patients prescribed zinc supplements","volume":"68","author":"Duncan","year":"2015","journal-title":"J\u00a0Clin Pathol"},{"issue":"6","key":"10.1016\/j.mcna.2016.09.011_bib10","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1111\/j.1600-0609.2008.01050.x","article-title":"Hematological manifestations of copper deficiency: a retrospective review","volume":"80","author":"Halfdanarson","year":"2008","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.mcna.2016.09.011_bib11","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1054\/blre.2001.0148","article-title":"Acquired thrombophilic syndromes","volume":"15","author":"Matei","year":"2001","journal-title":"Blood Rev"},{"key":"10.1016\/j.mcna.2016.09.011_bib12","first-page":"103","article-title":"Paroxysmal nocturnal hemoglobinuria and the risk of venous thrombosis: review and recommendations for management of the pregnant and nonpregnant patient","volume":"30","author":"Ray","year":"2000","journal-title":"Haemostasis"},{"key":"10.1016\/j.mcna.2016.09.011_bib13","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S0140-6736(95)12360-1","article-title":"Paroxysmal nocturnal haemoglobinuria: long-term follow-up and prognostic factors. French Society of Haematology","volume":"348","author":"Socie","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.mcna.2016.09.011_bib14","first-page":"697","article-title":"Activated platelets in paroxysmal nocturnal haemoglobinuria","volume":"91","author":"Gralnick","year":"1995","journal-title":"Liver"},{"issue":"12","key":"10.1016\/j.mcna.2016.09.011_bib15","doi-asserted-by":"crossref","first-page":"3699","DOI":"10.1182\/blood-2005-04-1717","article-title":"Diagnosis and management of paroxysmal nocturnal hemoglobinuria","volume":"106","author":"Parker","year":"2005","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.mcna.2016.09.011_bib16","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1002\/ajh.23612","article-title":"Laboratory tests for paroxysmal nocturnal hemoglobinuria","volume":"89","author":"Preis","year":"2014","journal-title":"Am J Hematol"},{"issue":"3","key":"10.1016\/j.mcna.2016.09.011_bib17","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1111\/ejh.12543","article-title":"Pathophysiology, diagnosis, and treatment of paroxysmal nocturnal hemoglobinuria: a review","volume":"95","author":"Devalet","year":"2015","journal-title":"Eur J Haematol"},{"issue":"12","key":"10.1016\/j.mcna.2016.09.011_bib18","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1056\/NEJMoa061648","article-title":"The complement inhibitor eculizumab in paroxysmal nocturnal hemoglobinuria","volume":"355","author":"Hillmen","year":"2006","journal-title":"N\u00a0Engl J Med"},{"issue":"12","key":"10.1016\/j.mcna.2016.09.011_bib19","doi-asserted-by":"crossref","first-page":"4123","DOI":"10.1182\/blood-2007-06-095646","article-title":"Effect of the complement inhibitor eculizumab on thromboembolism in patients with paroxysmal nocturnal hemoglobinuria","volume":"110","author":"Hillmen","year":"2007","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.mcna.2016.09.011_bib20","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/j.1365-2141.2009.07842.x","article-title":"Guidelines for the diagnosis and management of aplastic anaemia","volume":"147","author":"Marsh","year":"2009","journal-title":"Br J Haematol"},{"issue":"4","key":"10.1016\/j.mcna.2016.09.011_bib21","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1002\/ccd.20795","article-title":"Percutaneous closure of prosthetic paravalvular leaks: case series and review","volume":"68","author":"Pate","year":"2006","journal-title":"Catheter Cardiovasc Interv"},{"issue":"6","key":"10.1016\/j.mcna.2016.09.011_bib22","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1182\/blood-2011-12-274019","article-title":"How I treat acquired aplastic anemia","volume":"120","author":"Scheinberg","year":"2012","journal-title":"Blood"},{"issue":"19","key":"10.1016\/j.mcna.2016.09.011_bib23","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1056\/NEJM199705083361906","article-title":"The pathophysiology of acquired aplastic anemia","volume":"336","author":"Young","year":"1997","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.mcna.2016.09.011_bib24","doi-asserted-by":"crossref","first-page":"52","DOI":"10.2165\/00003495-198631010-00004","article-title":"Drug-induced aplastic anaemia and agranulocytosis. Incidence and mechanisms","volume":"31","author":"Vincent","year":"1986","journal-title":"Drugs"},{"key":"10.1016\/j.mcna.2016.09.011_bib25","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/j.1600-0609.1996.tb01641.x","article-title":"Drugs in the aetiology of agranulocytosis and aplastic anaemia","volume":"60","author":"Kaufman","year":"1996","journal-title":"Eur J Haematol Suppl"},{"key":"10.1016\/j.mcna.2016.09.011_bib26","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/j.1600-0609.1996.tb01644.x","article-title":"Drug-related blood dyscrasias in a Swedish reporting system, 1985-1994","volume":"60","author":"Wiholm","year":"1996","journal-title":"Eur J Haematol Suppl"},{"key":"10.1016\/j.mcna.2016.09.011_bib27","series-title":"Blood: principles and practice of hematology","first-page":"293","article-title":"Acquired aplastic anemia","author":"Young","year":"1995"},{"issue":"11","key":"10.1016\/j.mcna.2016.09.011_bib28","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1177\/1060028014547078","article-title":"Recent developments in drug therapy for aplastic anemia","volume":"48","author":"Willis","year":"2014","journal-title":"Ann Pharmacother"},{"issue":"22","key":"10.1016\/j.mcna.2016.09.011_bib29","doi-asserted-by":"crossref","first-page":"3561","DOI":"10.1182\/blood-2013-05-498279","article-title":"Management of the refractory aplastic anemia patient: what are the options?","volume":"122","author":"Marsh","year":"2013","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.mcna.2016.09.011_bib30","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1200931","article-title":"Eltrombopag and improved hematopoiesis in refractory aplastic anemia","volume":"367","author":"Olnes","year":"2012","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.mcna.2016.09.011_bib31","doi-asserted-by":"crossref","DOI":"10.1111\/bjh.14024","article-title":"The thrombopoietin mimetics eltrombopag and romiplostim in the treatment of refractory aplastic anaemia","author":"Gill","year":"2016","journal-title":"Br J Haematol"},{"issue":"4","key":"10.1016\/j.mcna.2016.09.011_bib32","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1053\/j.seminhematol.2015.07.002","article-title":"Anemia of central origin","volume":"52","author":"Ishii","year":"2015","journal-title":"Semin Hematol"},{"issue":"4","key":"10.1016\/j.mcna.2016.09.011_bib33","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1111\/j.1365-2141.2008.07216.x","article-title":"Acquired pure red cell aplasia: updated review of treatment","volume":"142","author":"Sawada","year":"2008","journal-title":"Br J Haematol"},{"issue":"4","key":"10.1016\/j.mcna.2016.09.011_bib34","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1046\/j.1365-2141.2000.02429.x","article-title":"Pure red cell aplasia","volume":"111","author":"Fisch","year":"2000","journal-title":"Br J Haematol"},{"issue":"3","key":"10.1016\/j.mcna.2016.09.011_bib35","doi-asserted-by":"crossref","first-page":"199","DOI":"10.4149\/av_2014_03_199","article-title":"Human parvovirus B19: a review","volume":"58","author":"Rogo","year":"2014","journal-title":"Acta Virol"},{"issue":"4","key":"10.1016\/j.mcna.2016.09.011_bib36","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/S0889-8561(05)70042-4","article-title":"Drug-induced immune hematologic disease","volume":"18","author":"DeLoughery","year":"1998","journal-title":"Immunol Allergy Clin N Am"},{"key":"10.1016\/j.mcna.2016.09.011_bib37","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S1387-2656(04)10008-2","article-title":"Drug-induced and antibody-mediated pure red cell aplasia: a review of literature and current knowledge","volume":"10","author":"Smalling","year":"2004","journal-title":"Biotechnol Annu Rev"},{"issue":"1386","key":"10.1016\/j.mcna.2016.09.011_bib38","first-page":"106","article-title":"Pure red cell aplasia associated with recombinant erythropoietin: a case report and brief review of the literature","volume":"126","author":"Mohd Slim","year":"2013","journal-title":"N\u00a0Z Med J"},{"issue":"2","key":"10.1016\/j.mcna.2016.09.011_bib39","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.hoc.2009.01.009","article-title":"Diagnosis and management of acquired pure red cell aplasia","volume":"23","author":"Sawada","year":"2009","journal-title":"Hematol Oncol Clin North Am"},{"issue":"10","key":"10.1016\/j.mcna.2016.09.011_bib40","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1136\/jcp.2003.015834","article-title":"How should stainable iron in bone marrow films be assessed?","volume":"57","author":"Hughes","year":"2004","journal-title":"J\u00a0Clin Pathol"},{"issue":"2","key":"10.1016\/j.mcna.2016.09.011_bib41","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1161\/01.HYP.0000151620.17905.ee","article-title":"Microangiopathic hemolysis and renal failure in malignant hypertension","volume":"45","author":"van den Born","year":"2005","journal-title":"Hypertension"},{"issue":"5","key":"10.1016\/j.mcna.2016.09.011_bib42","first-page":"343","article-title":"Percutaneous mitral valve repair using the edge-to-edge technique: first Greek experience","volume":"53","author":"Spargias","year":"2012","journal-title":"Hellenic J Cardiol"},{"issue":"8","key":"10.1016\/j.mcna.2016.09.011_bib43","doi-asserted-by":"crossref","first-page":"081002","DOI":"10.1115\/1.4007092","article-title":"A\u00a0quantitative comparison of mechanical blood damage parameters in rotary ventricular assist devices: shear stress, exposure time and hemolysis index","volume":"134","author":"Fraser","year":"2012","journal-title":"J\u00a0Biomech Eng"},{"issue":"1","key":"10.1016\/j.mcna.2016.09.011_bib44","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.healun.2013.11.010","article-title":"Ambient hemolysis and activation of coagulation is different between HeartMate II and HeartWare left ventricular assist devices","volume":"33","author":"Birschmann","year":"2014","journal-title":"J\u00a0Heart Lung Transplant"},{"issue":"9","key":"10.1016\/j.mcna.2016.09.011_bib45","first-page":"343","article-title":"Clostridium perfringens septicaemia with massive intravascular haemolysis: a case report and review of the literature","volume":"68","author":"van Bunderen","year":"2010","journal-title":"Neth J Med"},{"issue":"4","key":"10.1016\/j.mcna.2016.09.011_bib46","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1111\/jgh.12473","article-title":"Presence of spur cells as a highly predictive factor of mortality in patients with cirrhosis","volume":"29","author":"Alexopoulou","year":"2014","journal-title":"J\u00a0Gastroenterol Hepatol"},{"issue":"10","key":"10.1016\/j.mcna.2016.09.011_bib47","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1097\/00007611-198210000-00013","article-title":"Spur cell anemia","volume":"75","author":"Doll","year":"1982","journal-title":"South Med J"},{"issue":"4 Pt 1","key":"10.1016\/j.mcna.2016.09.011_bib48","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1203\/01.pdr.0000203098.77573.39","article-title":"Erythrocyte metabolism and antioxidant status of patients with Wilson disease with hemolytic anemia","volume":"59","author":"Attri","year":"2006","journal-title":"Pediatr Res"},{"issue":"9","key":"10.1016\/j.mcna.2016.09.011_bib49","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1097\/00003246-199209000-00015","article-title":"Hematologic changes in massive burn injury","volume":"20","author":"Lawrence","year":"1992","journal-title":"Crit Care Med"}],"container-title":["Medical Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002571251637362X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002571251637362X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,21]],"date-time":"2024-06-21T03:32:56Z","timestamp":1718940776000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002571251637362X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3]]},"references-count":49,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,3]]}},"alternative-id":["S002571251637362X"],"URL":"https:\/\/doi.org\/10.1016\/j.mcna.2016.09.011","relation":{},"ISSN":["0025-7125"],"issn-type":[{"value":"0025-7125","type":"print"}],"subject":[],"published":{"date-parts":[[2017,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Unusual Anemias","name":"articletitle","label":"Article Title"},{"value":"Medical Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mcna.2016.09.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}